These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36105404)

  • 1. Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial.
    Dubský M; Husáková J; Bem R; Jirkovská A; Němcová A; Fejfarová V; Sutoris K; Kahle M; Jude EB
    Front Endocrinol (Lausanne); 2022; 13():888809. PubMed ID: 36105404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells.
    Arango-Rodríguez ML; Mateus LC; Sossa CL; Becerra-Bayona SM; Solarte-David VA; Ochoa Vera ME; Viviescas LTG; Berrio AMV; Serrano SE; Vargas O; Isla AC; Benitez A; Rangel G
    Stem Cell Res Ther; 2023 Aug; 14(1):221. PubMed ID: 37626416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy.
    Husakova J; Bem R; Fejfarova V; Jirkovska A; Woskova V; Jarosikova R; Lovasova V; Jude EB; Dubsky M
    J Diabetes Res; 2022; 2022():3954740. PubMed ID: 35450383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers.
    Panunzi A; Madotto F; Sangalli E; Riccio F; Sganzaroli AB; Galenda P; Bertulessi A; Barmina MF; Ludovico O; Fortunato O; Setacci F; Airoldi F; Tavano D; Giurato L; Meloni M; Uccioli L; Bruno A; Spinetti G; Caravaggi CMF
    Cardiovasc Diabetol; 2022 Sep; 21(1):196. PubMed ID: 36171587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TcPO2 Value Can Predict Wound Healing Time in Clinical Practice of CLTI Patients.
    Woo Y; Suh YJ; Lee H; Jeong E; Park SC; Yun SS; Kim JY
    Ann Vasc Surg; 2023 Apr; 91():249-256. PubMed ID: 36503018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers-Do We Have Enough Evidence?
    Dubský M; Husáková J; Sojáková D; Fejfarová V; Jude EB
    Mol Diagn Ther; 2023 Nov; 27(6):673-683. PubMed ID: 37740111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.
    Dubský M; Jirkovská A; Bem R; Němcová A; Fejfarová V; Hazdrová J; Sutoris K; Chlupáč J; Skibová J; Jude EB
    Diabet Med; 2019 Sep; 36(9):1133-1140. PubMed ID: 31077439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Three Methods for Preparation of Autologous Cells for Use in Cell Therapy of Chronic Limb-Threatening Ischemia in People with Diabetes.
    Husakova J; Bem R; Jirkovska A; Nemcova A; Fejfarova V; Sutoris K; Kahle M; Jude EB; Dubsky M
    Int J Low Extrem Wounds; 2022 Apr; ():15347346221095954. PubMed ID: 35466748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia.
    Petrakis E; Sciacca V
    Int Angiol; 2000 Mar; 19(1):18-25. PubMed ID: 10853681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Algorithm for balloon angioplasty in patients with critical limb ischemia with diabetic foot syndrome].
    Futuyma YABCDEFBCEFBCDEF; Kulbaba I; Kritsak M; Konowalenko S
    Pol Merkur Lekarski; 2022 Dec; 50(300):370-373. PubMed ID: 36645683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient presenting with chronic limb-threatening ischaemia. Does diabetes influence presentation, limb outcomes and survival?
    Fitridge R; Pena G; Mills JL
    Diabetes Metab Res Rev; 2020 Mar; 36 Suppl 1():e3242. PubMed ID: 31867854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.
    Dubský M; Jirkovská A; Bem R; Fejfarová V; Pagacová L; Nemcová A; Sixta B; Chlupac J; Peregrin JH; Syková E; Jude EB
    Cytotherapy; 2014 Dec; 16(12):1733-8. PubMed ID: 25304666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems.
    Ballard JL; Eke CC; Bunt TJ; Killeen JD
    J Vasc Surg; 1995 Oct; 22(4):485-90; discussion 490-2. PubMed ID: 7563410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraprocedural Transcutaneous Oxygen Pressure and Systolic Toe Pressure Measurements During and After Endovascular Intervention in Patients with Chronic Limb Threatening Ischaemia.
    Gunnarsson T; Lindgren H; Gottsäter A; Pärsson H
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):583-589. PubMed ID: 34334314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty.
    Nemcova A; Jirkovska A; Dubsky M; Kolesar L; Bem R; Fejfarova V; Pysna A; Woskova V; Skibova J; Jude EB
    Cell Transplant; 2018 Sep; 27(9):1368-1374. PubMed ID: 29860903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Degree of Blood Supply and Infection Control Needed to Treat Diabetic Chronic Limb-Threatening Ischemia with Forefoot Osteomyelitis.
    Fujii M; Terashi H; Yokono K; Armstrong DG
    J Am Podiatr Med Assoc; 2021 Mar; 111(2):. PubMed ID: 33872358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol Can Increase Skin Oxygen Supply Assessed by Transcutaneous Oxygen Pressure Measurement in Type 2 Diabetes With Lower Limb Ischemic Disease: A Randomized Trial.
    Zhang J; Xiao Z; Chen L; Li L; Yang H; Luo B; Mai L; Yan L; Yang C
    J Wound Ostomy Continence Nurs; 2016; 43(3):254-9. PubMed ID: 26938333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial.
    Norgren L; Weiss N; Nikol S; Lantis JC; Patel MR; Hinchliffe RJ; Reinecke H; Volk HD; Reinke P; Fadini GP; Ofir R; Rothenstein D; Halevy N; Karagjozov M; Rundback JH
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38294084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.